Device / Technology News

RSS

FDA clears ZOLL's new Propaq MD Monitor/Defibrillator

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market and begin distribution of the new Propaq® MD Monitor/Defibrillator that was developed specifically to meet the special needs of military customers and air medical operations worldwide. Development of this product was a joint undertaking between the Department of Defense and a cooperative arrangement between Welch Allyn and ZOLL.

30 Jul 2010

Opportunity in European embolization coil market leads to major acquisitions in 2010: MRG

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, high market opportunity in the European embolization coil market has led to several major acquisitions in 2010. The European market alone was valued at approximately $100 million in 2009, making successful niche competitors in this market attractive acquisition targets.

30 Jul 2010

VAPAHCS acquires 15 Zargis Cardioscan systems

Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp., today announced that the VA Palo Alto Health Care System, a northern California based hospital group that is part of The Department of Veterans Affairs nationwide network of hospitals, recently purchased 15 Zargis Cardioscan systems.

30 Jul 2010

Down the silk road of the future

The Science paper notes that the development of silk hydrogels, films, fibers and sponges is making possible advances in photonics and optics, nanotechnology, electronics, adhesives and microfluidics, as well as engineering of bone and ligaments. Because silk fiber formation does not rely on complex or toxic chemistries, such materials are biologically and environmentally friendly, even able to integrate with living systems.

30 Jul 2010

FDA clears Hotspur's new balloon dilatation and embolectomy catheters

Hotspur Technologies, Inc. announced today that it has received FDA clearance for the first three commercial products in its portfolio. These products are based on Hotspur's unique and groundbreaking technology that makes dialysis access interventional and peripheral vascular procedures that open blood vessels less expensive, more efficient, and less invasive for patients.

30 Jul 2010

Exoskeletons, powered prostheses and optical sensory devices market to exceed $877 million in 2020: Study

Lockheed Martin announced recently that it has received a $1.1-million contract from the US Army for human trials and evaluation of its advanced ruggedized Human Universal Load Carrier (HULC) exoskeleton, "designed to augment soldiers' strength and endurance, as well as reduce load carriage injuries."

30 Jul 2010

Gen-Probe second-quarter 2010 product sales up 14%

Gen-Probe Incorporated today reported financial results for the second quarter of 2010, highlighted by 14% growth in product sales, 15% growth in total revenues, and 16% growth in non-GAAP earnings per share.

30 Jul 2010

Computer game to help nursing students pass exams

A specially made computer game, developed at the University of Stavanger (UiS), is set to help Norwegian nursing students pass a vitally important exam.

30 Jul 2010

Buckyball Discovery Conference to be held Oct. 10-13 at Rice University

The biggest names in nanotechnology are preparing to gather this fall at Rice University, and everyone is welcome to join them.

30 Jul 2010

Hitachi High-Tech releases HT7700 transmission electron microscope

Hitachi High-Technologies Corporation has announced the development and release of the HT7700, a new type of transmission electron microscope (TEM) that integrates previously complex system operation onto a single monitor screen, and allows for sample observation even under normal room light conditions. Sales of the HT7700 will begin outside of Japan in August 2010.

30 Jul 2010

FDA approves two SCS leads for use with Boston Scientific's Precision Plus Spinal Cord Stimulator System

Boston Scientific Corporation today announced U.S. Food and Drug Administration approval of two spinal cord stimulation (SCS) leads for use with its Precision Plus™ Spinal Cord Stimulator System, the world's first rechargeable SCS device for the management of chronic pain of the trunk and/or limbs. The Linear™ 3-4 and Linear™ 3-6 Percutaneous Leads offer wider contact spacing to expand the lead choices available to physicians. The Company plans to launch the products immediately in the U.S.; they were launched in Europe and other international markets earlier.

30 Jul 2010

VitaPath Genetics launches VitaTrack Folate Tracker

VitaPath Genetics, the Spina Bifida Association and the National Council on Folic Acid today announced the launch of the free iPhone application—the VitaTrack Folate Tracker— which allows women to track their daily intake of folate and folic acid. Maintaining an adequate level of folic acid prior to and during pregnancy can reduce the risk of serious birth defects like Spina Bifida by up to 70%. Studies show that folic acid may also help prevent congenital heart disease, pre-term labor, and cleft lip and palate.

30 Jul 2010

MSP announces enhancements to EHR Selector

Medical Strategic Planning announces enhancements to the widely-used EHR Selector, which empowers Regional Extension Centers to quickly qualify EHR products and individually track thousands of practices deploying critically-vetted electronic health record solutions.

30 Jul 2010

ISMPP and MPIP initiative launches new web page

On July 29, 2010 the International Society for Medical Publication Professionals (ISMPP) and the Medical Publishing Insights and Practices (MPIP) initiative launched a new web page highlighting various MPIP initiatives (http://www.mpip-initiative.org). The web page is a valuable resource providing information on the overall MPIP initiative, updating viewers on new or planned activities, and providing access to previous MPIP publications and resources.

30 Jul 2010

Funding for electronic medical records expected as early as May, already stimulating business

Modern Healthcare: Funding to help doctors and hospitals buy electronic medical records could begin to flow through the Medicare program as early as May 2011, a Centers for Medicare and Medicaid Services official said Wednesday. But, the final shape of the program remains unclear as CMS works to implement 800 pages of new regulations. "We're now working toward actually making all of this a reality, and we have less than six months to do it," the official said (Conn, 7/28).

30 Jul 2010

Helicos' single-molecule sequencing technology for detection, quantification of novel small RNA

Helicos BioSciences Corporation today announced a publication demonstrating the detection and quantification of novel small RNA molecules using Helicos' single-molecule sequencing technology. These data confirm a long-held, unproven hypothesis that mammalian cells are capable of synthesizing RNA by copying RNA molecules directly.

30 Jul 2010

Biotage launches Isolera ELSD-1080 evaporative light-scattering detector for flash purification

Biotage, a leading supplier of tools and technology for medicinal and analytical chemistry, announced the launch of the Isolera ELSD-1080 evaporative light-scattering detector for flash purification. With the addition of the ELSD-1080, Biotage now provides a flash purification solution for nearly every compound type including semi-volatile UV transparent as well as UV absorbing compounds.

30 Jul 2010

Cerus second-quarter product revenue for INTERCEPT Blood System increases 47% to $5.7 million

Cerus Corporation today announced financial results for the second quarter ended June 30, 2010.

30 Jul 2010

Bio-Path commences dosing in Liposomal Grb-2 Phase I cancer study

Bio-Path Holdings, Inc.,, a biotechnology company with drug development operations in Houston, Texas, announced today that the first patient has been dosed in a Phase I study of its cancer drug candidate, Liposomal Grb-2 (L-Grb-2 or BP-100-1.01), in patients with Acute Myeloid Leukemia (AML), Chronic Myelogenous Leukemia (CML), Acute Lymphoblastic Leukemia (ALL) or Myelodysplastic Syndrome (MDS).

30 Jul 2010

AdvanDx's 90 minutes protocol for Yeast Traffic Light PNA FISH test receives FDA 510(k) clearance

AdvanDx today announced that it has received FDA 510(k) clearance for a fast, 90 minutes protocol for its Yeast Traffic Light® PNA FISH® test. The faster protocol reduces the PNA FISH turn-around time from the original 2.5 hours to 90 minutes by reducing PNA probe hybridization from 90 minutes to 30 minutes.

30 Jul 2010

Device / Technology News

FDA clears ZOLL's new Propaq MD Monitor/Defibrillator

Opportunity in European embolization coil market leads to major acquisitions in 2010: MRG

VAPAHCS acquires 15 Zargis Cardioscan systems

Down the silk road of the future

FDA clears Hotspur's new balloon dilatation and embolectomy catheters

Exoskeletons, powered prostheses and optical sensory devices market to exceed $877 million in 2020: Study

Gen-Probe second-quarter 2010 product sales up 14%

Computer game to help nursing students pass exams

Buckyball Discovery Conference to be held Oct. 10-13 at Rice University

Hitachi High-Tech releases HT7700 transmission electron microscope

FDA approves two SCS leads for use with Boston Scientific's Precision Plus Spinal Cord Stimulator System

VitaPath Genetics launches VitaTrack Folate Tracker

MSP announces enhancements to EHR Selector

ISMPP and MPIP initiative launches new web page

Funding for electronic medical records expected as early as May, already stimulating business

Helicos' single-molecule sequencing technology for detection, quantification of novel small RNA

Biotage launches Isolera ELSD-1080 evaporative light-scattering detector for flash purification

Cerus second-quarter product revenue for INTERCEPT Blood System increases 47% to $5.7 million

Bio-Path commences dosing in Liposomal Grb-2 Phase I cancer study

AdvanDx's 90 minutes protocol for Yeast Traffic Light PNA FISH test receives FDA 510(k) clearance

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Latest News